# Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia

> **NCT01683604** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 37 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** Observational study

## Key facts

- **NCT ID:** NCT01683604
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683604, "Observational Study of Tocilizumab in Participants With Rheumatoid Arthritis in Australia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01683604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*